Barco公司开发出用于三维血管分析的软件

一种新型软件模块为放射科医生提供了一种血管分析系统，能够有效评估对比增强计算机X线断层血管成像术和核磁共振检查评估血管狭窄、支架和支架放置计划、以及支架放置监测。

这种三维VesselMetrix模块是由Barco公司开发的，最近刚刚获得美国食品药品管理局的许可。Voxar产品小组总经理Craig Anderson指出："VesselMetirx得到了我们客户和PACS(图像存档和通信系统)合作伙伴的认可，因为它易于操作，工作稳定可靠。它使得放射科医生在阅读血管成像资料的时候，对质量和效率制定新的标准。"

他说："我们的客户和PACS合作伙伴需要三维临床应用软件，要求用户界面友好并能够提高工作效率。VeslMetrix满足了血管成像研究的要求，达到了我们为放射科医生提供他们所需要的能够有效阅读庞大的测定容量数据研究的基本要求。"
 
Software for 3D Vessel Analysis
 
A new software module provides radiologists with a vessel analysis system to effectively assess contrast-enhanced computed tomography angiography (CTA) and magnetic resonance angiography (MRA) studies for evaluating stenosis, stent and stent graft planning, and stent graft monitoring.

The 3D (three-dimensional) VesselMetrix module, developed by Barco (Kortrijk, Belgium), has just been cleared by the U.S. Food and Drug Administration (FDA). “VesselMetrix was very well received by our customers and PACS [picture archiving and communications system] partners because of its ease-of-use and incredibly fast performance. It allows radiologists to set new standards in quality and efficiency when reading angiographic studies,” stated Craig Anderson, general manager of the Voxar product group.

“Our customers and PACS partners need 3D-enabled clinical software applications that are user-friendly and optimized to increase productivity. VeselMetrix delivers this for angiographic studies and is fundamental to our goal of providing radiologists with the tools they need to effectively read large volumetric data studies,” he added.